Biden cancer charity scandal: Millions spent on salaries, ZERO on research

Biden cancer charity scandal: Millions spent on salaries, ZERO on research – a betrayal of trust?

By willowt // 2025-02-27

Mastodon

Parler

Gab

Copy

Tax filings show the Biden Cancer Initiative spent millions on staff salaries and conferences but distributed zero dollars to cancer research, raising concerns about fund misuse.
Top executives, including President Gregory Simon, received six-figure salaries, with Simon earning nearly $430,000 in 2018 alone.
Despite claims of accelerating cancer treatment accessibility, the charity failed to deliver measurable results or provide grants to researchers or institutions.
The scandal is part of broader concerns about the Biden family's ethical standards, adding to questions about their integrity and accountability.
The incident highlights the need for greater oversight and accountability in the nonprofit sector, particularly in light of the urgent need for cancer research advancements.

In a shocking revelation that has left many Americans questioning the integrity of one of the nation’s most prominent political families, tax filings have exposed that the Biden Cancer Initiative, a charity founded by Joe and Jill Biden, spent millions on staff salaries and lavish expenses while distributing zero dollars toward cancer research. This scandal, first reported by The New York Post and corroborated by DailyMail.com, raises serious concerns about the misuse of charitable funds and the ethical standards of those entrusted with the public’s trust.

A noble mission, a questionable execution

The Biden Cancer Initiative was launched in 2017 with a lofty mission: to “develop and drive implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research and care, and to reduce disparities in cancer outcomes.” The charity was established in the wake of Beau Biden’s tragic death from brain cancer in 2015, a deeply personal loss for the Biden family. At the time, the initiative was heralded as a beacon of hope for cancer patients and their families, promising to deliver “urgent” solutions to a disease that claims hundreds of thousands of lives annually. However, tax filings from 2017 and 2018 reveal a starkly different reality. The charity raised 4,809,619 in contributions during its first two years but allocated not a single dollar toward research grants. Instead, the bulk of the funds — $3,070,301 — was spent on staff salaries, with top executives raking in six-figure paychecks. Gregory Simon, the charity’s president and a former Pfizer executive, pocketed $429,850 in 2018 alone, nearly double his 2017 salary of $224,539. Danielle Carnival, former chief of staff for Obama’s Cancer Moonshot Task Force, took home $258,207 in 2018.

Lavish spending, zero accountability

The charity’s spending habits raise further red flags. In 2018, the Biden Cancer Initiative spent $97,149 on travel and a staggering $742,953 on conferences. These expenses, combined with the exorbitant salaries, paint a picture of an organization more focused on self-enrichment than on fulfilling its stated mission. While the charity claimed its primary goal was to accelerate cancer treatment accessibility rather than fund research, the lack of tangible outcomes and the absence of grants distributed to researchers or institutions undermine its credibility. Gregory Simon defended the charity’s approach in a 2019 interview, stating, “The main point of the charity was not to give out grants, and that its goal was to find ways to accelerate treatment for all, regardless of their economic or cultural backgrounds.” Yet, without measurable results or financial contributions to the cause, such claims ring hollow. The charity’s failure to deliver on its promises is a betrayal of the trust placed in it by donors and the public.

A pattern of ethical lapses?

This scandal is not an isolated incident but rather part of a broader pattern of questionable behavior surrounding the Biden family. President Donald Trump has repeatedly accused the Bidens of running a “criminal enterprise,” citing allegations of corruption involving foreign business dealings. While these claims remain contentious, the revelations about the Biden Cancer Initiative add fuel to the fire, raising legitimate concerns about the family’s ethical standards. Historically, charitable organizations have been held to the highest standards of accountability and transparency. The American public has long supported charities with the expectation that their donations will be used to advance noble causes, not to line the pockets of executives. The Biden Cancer Initiative’s misuse of funds is a stark reminder of the need for rigorous oversight and accountability in the nonprofit sector.

A call for transparency and reform

The Biden Cancer Initiative’s failure to allocate funds toward research is particularly egregious given the urgent need for advancements in cancer treatment. Cancer remains the second leading cause of death in the United States, with an estimated 1.9 million new cases diagnosed in 2023 alone. The charity’s inability to deliver on its promises is a disservice to the millions of Americans affected by this devastating disease. The Biden Cancer Initiative scandal is a wake-up call for greater accountability in both the nonprofit sector and the political arena. In the words of one disillusioned donor, “We gave our money in good faith, hoping it would make a difference. To see it wasted on salaries and conferences is heartbreaking.” It is time for the Bidens to answer for their actions and for the public to demand better from their leaders. The fight against cancer is too important to be derailed by greed and mismanagement. Sources include: NYPost.com DailyMail.com RT.com